Kewaunee Scientific Corporation

NasdaqGM:KEQU Stock Report

Market Cap: US$154.7m

Kewaunee Scientific Management

Management criteria checks 2/4

Kewaunee Scientific's CEO is Thomas Hull, appointed in Mar 2019, has a tenure of 5.75 years. total yearly compensation is $2.12M, comprised of 20.3% salary and 79.7% bonuses, including company stock and options. directly owns 1.55% of the company’s shares, worth $2.40M. The average tenure of the management team and the board of directors is 5.8 years and 12.5 years respectively.

Key information

Thomas Hull

Chief executive officer

US$2.1m

Total compensation

CEO salary percentage20.3%
CEO tenure5.8yrs
CEO ownership1.5%
Management average tenure5.8yrs
Board average tenure12.5yrs

Recent management updates

Recent updates

Kewaunee Scientific: Growth Has Been Priced In After Q2 2025 Report

Dec 16

The Excitement Around Kewaunee Scientific Corporation's Business Turnaround Is Dying Out

Sep 24

Kewaunee Scientific Corporation (NASDAQ:KEQU) Looks Inexpensive After Falling 25% But Perhaps Not Attractive Enough

Sep 17
Kewaunee Scientific Corporation (NASDAQ:KEQU) Looks Inexpensive After Falling 25% But Perhaps Not Attractive Enough

With EPS Growth And More, Kewaunee Scientific (NASDAQ:KEQU) Makes An Interesting Case

Sep 10
With EPS Growth And More, Kewaunee Scientific (NASDAQ:KEQU) Makes An Interesting Case

Kewaunee Scientific (NASDAQ:KEQU) Is Doing The Right Things To Multiply Its Share Price

Aug 23
Kewaunee Scientific (NASDAQ:KEQU) Is Doing The Right Things To Multiply Its Share Price

Concerns Surrounding Kewaunee Scientific's (NASDAQ:KEQU) Performance

Jul 11
Concerns Surrounding Kewaunee Scientific's (NASDAQ:KEQU) Performance

Kewaunee Scientific (NASDAQ:KEQU) Has A Pretty Healthy Balance Sheet

Jun 19
Kewaunee Scientific (NASDAQ:KEQU) Has A Pretty Healthy Balance Sheet

Even With A 26% Surge, Cautious Investors Are Not Rewarding Kewaunee Scientific Corporation's (NASDAQ:KEQU) Performance Completely

Dec 18
Even With A 26% Surge, Cautious Investors Are Not Rewarding Kewaunee Scientific Corporation's (NASDAQ:KEQU) Performance Completely

Investors Could Be Concerned With Kewaunee Scientific's (NASDAQ:KEQU) Returns On Capital

Jul 02
Investors Could Be Concerned With Kewaunee Scientific's (NASDAQ:KEQU) Returns On Capital

Kewaunee Scientific (NASDAQ:KEQU) Has A Somewhat Strained Balance Sheet

Mar 10
Kewaunee Scientific (NASDAQ:KEQU) Has A Somewhat Strained Balance Sheet

Kewaunee Scientific GAAP EPS of -$0.27, revenue of $50.12M

Sep 08

Kewaunee Scientific GAAP EPS of -$0.13, revenue of $49.72M

Jun 30

Is Kewaunee Scientific (NASDAQ:KEQU) Weighed On By Its Debt Load?

Apr 12
Is Kewaunee Scientific (NASDAQ:KEQU) Weighed On By Its Debt Load?

Here's Why Kewaunee Scientific (NASDAQ:KEQU) Can Afford Some Debt

Dec 28
Here's Why Kewaunee Scientific (NASDAQ:KEQU) Can Afford Some Debt

Kewaunee Scientific reports Q2 results

Dec 09

CEO Compensation Analysis

How has Thomas Hull's remuneration changed compared to Kewaunee Scientific's earnings?
DateTotal CompensationSalaryCompany Earnings
Oct 31 2024n/an/a

US$19m

Jul 31 2024n/an/a

US$18m

Apr 30 2024US$2mUS$431k

US$19m

Jan 31 2024n/an/a

US$9m

Oct 31 2023n/an/a

US$7m

Jul 31 2023n/an/a

US$4m

Apr 30 2023US$966kUS$384k

US$738k

Jan 31 2023n/an/a

-US$629k

Oct 31 2022n/an/a

-US$3m

Jul 31 2022n/an/a

-US$6m

Apr 30 2022US$870kUS$371k

-US$6m

Jan 31 2022n/an/a

-US$9m

Oct 31 2021n/an/a

-US$7m

Jul 31 2021n/an/a

-US$4m

Apr 30 2021US$707kUS$350k

-US$4m

Jan 31 2021n/an/a

-US$2m

Oct 31 2020n/an/a

-US$4m

Jul 31 2020n/an/a

-US$6m

Apr 30 2020US$674kUS$350k

-US$5m

Jan 31 2020n/an/a

-US$5m

Oct 31 2019n/an/a

-US$3m

Jul 31 2019n/an/a

US$511k

Apr 30 2019US$404kUS$280k

US$2m

Jan 31 2019n/an/a

US$4m

Oct 31 2018n/an/a

US$5m

Jul 31 2018n/an/a

US$6m

Apr 30 2018US$517kUS$262k

US$5m

Compensation vs Market: Thomas's total compensation ($USD2.12M) is above average for companies of similar size in the US market ($USD1.41M).

Compensation vs Earnings: Thomas's compensation has increased by more than 20% in the past year.


CEO

Thomas Hull (48 yo)

5.8yrs

Tenure

US$2,120,403

Compensation

Mr. Thomas D. Hull, III, has been President and Chief Executive Officer at Kewaunee Scientific Corporation since March 11, 2019 and served as its Chief Financial Officer since November 1, 2015 until April...


Leadership Team

NamePositionTenureCompensationOwnership
Thomas Hull
President5.8yrsUS$2.12m1.55%
$ 2.4m
Donald Gardner
VP of Finance5.7yrsUS$952.98k0.86%
$ 1.3m
Douglas Batdorff
Vice President of Manufacturing Operations4.5yrsUS$551.67k0.29%
$ 456.3k
Ryan Noble
Vice President of Sales & Marketing - Americas6.4yrsUS$333.87k0.46%
$ 717.7k
Elizabeth Phillips
Vice President of Human Resources15.5yrsno data0.47%
$ 732.2k
Bhoopathy Sathyamurthy
Managing Director of International Operationsno datano datano data

5.8yrs

Average Tenure

47.5yo

Average Age

Experienced Management: KEQU's management team is seasoned and experienced (5.8 years average tenure).


Board Members

NamePositionTenureCompensationOwnership
Thomas Hull
President5.8yrsUS$2.12m1.55%
$ 2.4m
Keith Gehl
Independent Director9.7yrsUS$115.00k0.58%
$ 894.1k
David Rhind
Independent Chairman16.7yrsUS$120.00k4.63%
$ 7.2m
Margaret Pyle
Independent Director29.8yrsUS$110.00k1.59%
$ 2.5m
Donald Shaw
Independent Director11.5yrsUS$110.00k0.87%
$ 1.3m
John Russell
Independent Director13.6yrsUS$110.00k1.13%
$ 1.8m

12.5yrs

Average Tenure

68yo

Average Age

Experienced Board: KEQU's board of directors are seasoned and experienced ( 12.5 years average tenure).


Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/23 12:04
End of Day Share Price 2024/12/23 00:00
Earnings2024/10/31
Annual Earnings2024/04/30

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Kewaunee Scientific Corporation is covered by 1 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
null nullCG Capital